Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TARA

Protara Therapeutics (TARA)

Protara Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TARA
DateTimeSourceHeadlineSymbolCompany
05/05/20228:00AMGlobeNewswire Inc.Protara Therapeutics Announces First Quarter 2022 Financial Results and Business OverviewNASDAQ:TARAProtara Therapeutics Inc
04/27/20224:12PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TARAProtara Therapeutics Inc
04/27/20224:07PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TARAProtara Therapeutics Inc
04/15/20226:35AMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:TARAProtara Therapeutics Inc
04/08/20226:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
03/24/20228:00AMGlobeNewswire Inc.Protara Therapeutics Doses First Patient in ADVANCED-1 Phase 1 Study of TARA-002 in Non-Muscle Invasive Bladder CancerNASDAQ:TARAProtara Therapeutics Inc
03/14/20224:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
03/10/20226:16AMTipRanksH.C. Wainwright Thinks Protara Therapeutics’ Stock is Going to RecoverNASDAQ:TARAProtara Therapeutics Inc
03/09/20224:34PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:TARAProtara Therapeutics Inc
03/09/20228:10AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:TARAProtara Therapeutics Inc
03/09/20227:48AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
03/09/20227:30AMGlobeNewswire Inc.Protara Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Business OverviewNASDAQ:TARAProtara Therapeutics Inc
03/02/20228:00AMGlobeNewswire Inc.Protara Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:TARAProtara Therapeutics Inc
02/15/20226:40AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TARAProtara Therapeutics Inc
02/15/20226:30AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TARAProtara Therapeutics Inc
02/14/20225:18PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TARAProtara Therapeutics Inc
02/11/20224:56PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TARAProtara Therapeutics Inc
02/01/20228:00AMGlobeNewswire Inc.Protara Therapeutics to Participate in the Guggenheim Healthcare Talks 2022 Oncology ConferenceNASDAQ:TARAProtara Therapeutics Inc
01/31/20224:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
01/12/20225:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
01/12/20225:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
01/12/20225:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
01/12/20225:14PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TARAProtara Therapeutics Inc
01/10/20228:24AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
01/10/20228:00AMGlobeNewswire Inc.Protara Therapeutics Announces Appointment of Jathin Bandari, M.D. as Chief Medical OfficerNASDAQ:TARAProtara Therapeutics Inc
01/05/20224:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
01/05/20224:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
01/04/20228:00AMGlobeNewswire Inc.Protara Therapeutics to Present at the H.C. Wainwright BioConnect Virtual ConferenceNASDAQ:TARAProtara Therapeutics Inc
12/27/20216:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
12/22/20214:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TARA